Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report

Saved in:
Bibliographic Details
Published in:Multiple sclerosis and related disorders 2020, Vol.44, p.102323-102323
Main Authors: Lucchini, Matteo, Bianco, Assunta, Del Giacomo, Paola, De Fino, Chiara, Nociti, Viviana, Mirabella, Massimiliano
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2211-0356
DOI:10.1016/j.msard.2020.102323